Pharmacokinetics and Biodistribution of 89Zr-Miltuximab and Its Antibody Fragments as Glypican-1 Targeting Immuno-PET Agents in Glioblastoma

体内分布 抗体 药代动力学 单克隆抗体 贪婪 癌症研究 正电子发射断层摄影术 化学 分子成像 体内 医学 核医学 药理学 免疫学 生物 体外 生物技术 生物化学
作者
Saikat Ghosh,Nicholas L. Fletcher,Pie Huda,Zachary H. Houston,Christopher B. Howard,Maria E. Lund,Yanling Lü,Douglas Houghton Campbell,Bradley J. Walsh,Kristofer J. Thurecht
出处
期刊:Molecular Pharmaceutics [American Chemical Society]
卷期号:20 (3): 1549-1563 被引量:6
标识
DOI:10.1021/acs.molpharmaceut.2c00760
摘要

Glioblastoma (GBM) is the most aggressive form of primary brain cancer, accounting for about 85% of all primary central nervous system (CNS) tumors. With standard treatment strategies like surgery, radiation, and chemotherapy, the median survival time of patients with GBM is only 12–15 months from diagnosis. The poor prognosis of GBM is due to a very high tumor recurrence rate following initial treatment, indicating a dire need for improved diagnostic and therapeutic alternatives for this disease. Antibody-based immunotheranostics holds great promise in treating GBM, combining the theranostic applications of radioisotopes and target-specificity of antibodies. In this study, we developed and validated antibody-based positron emission tomography (PET) tracers targeting the heparan sulfate proteoglycan, glypican-1 (GPC-1), for noninvasive detection of disease using diagnostic molecular imaging. GPC-1 is overexpressed in multiple solid tumor types, including GBM, and is a promising biomarker for novel immunotheranostics. Here, we investigate zirconium-89 (89Zr)-conjugated Miltuximab (a clinical stage anti-GPC-1 monoclonal antibody developed by GlyTherix, Ltd.) and engineered fragments for their potential as immuno-PET tracers to detect GPC-1positive GBM tumors in preclinical models. We explore the effects of molecular size, avidity, and Fc-domain on the pharmacokinetics and biodistribution in vivo, by comparing in parallel the full-length antibody (Miltuximab), Fab′2, Fab, and single-chain variable fragment (scFv) formats. High radiolabeling efficiency (>95%) was demonstrated by all the formats and the stability post-radiolabeling was higher for larger constructs of Miltuximab and the Fab. Receptor-mediated internalization of all 89Zr-labeled formats was observed in a human GBM cell line in vitro, while full-length Miltuximab demonstrated the highest tumor retention (5.7 ± 0.94% ID/g, day-9 postinjection (p.i.)) and overall better tumor-to-background ratios than the smaller Fc-less formats. Results from in vivo PET image quantification and ex vivo scintillation counting were highly correlated. Altogether, 89Zr-DFO-Miltuximab appears to be an effective immuno-PET imaging agent for detecting GPC-1positive tumors such as GBM and the current results support utility of the Fc containing whole mAb format over smaller antibody fragments for this target.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
欢歌笑语完成签到,获得积分10
刚刚
刚刚
老迟到的衫完成签到,获得积分20
1秒前
1秒前
GXSH发布了新的文献求助10
2秒前
Mrande发布了新的文献求助10
2秒前
共享精神应助lilili采纳,获得30
2秒前
深情安青应助眼睛大白昼采纳,获得10
2秒前
李明明发布了新的文献求助10
3秒前
头头啊头头啊完成签到,获得积分10
3秒前
momochichu完成签到,获得积分10
3秒前
3秒前
4秒前
4秒前
852应助欣欣子采纳,获得10
4秒前
开朗的雁开完成签到,获得积分10
4秒前
jie完成签到,获得积分10
4秒前
4秒前
Lucas应助风中小夏采纳,获得10
5秒前
Zoey完成签到,获得积分10
5秒前
makus发布了新的文献求助10
5秒前
Llllllxxxxxxx完成签到,获得积分10
5秒前
7秒前
迷人乐荷发布了新的文献求助10
7秒前
快乐小熊猫完成签到,获得积分10
8秒前
小陶子完成签到,获得积分10
8秒前
科yt完成签到,获得积分10
9秒前
9秒前
9秒前
阿玲完成签到,获得积分10
10秒前
完美世界应助果蝇之母采纳,获得10
10秒前
科研小白完成签到,获得积分10
10秒前
丘比特应助辛晨晨采纳,获得10
11秒前
洪武完成签到,获得积分10
11秒前
菠萝汁完成签到,获得积分10
11秒前
12秒前
beiest完成签到,获得积分10
12秒前
狒狒公主完成签到,获得积分10
12秒前
潘潘完成签到,获得积分10
12秒前
高分求助中
A new approach to the extrapolation of accelerated life test data 1000
Cognitive Neuroscience: The Biology of the Mind 1000
Technical Brochure TB 814: LPIT applications in HV gas insulated switchgear 1000
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 500
Picture Books with Same-sex Parented Families: Unintentional Censorship 500
Nucleophilic substitution in azasydnone-modified dinitroanisoles 500
不知道标题是什么 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3969094
求助须知:如何正确求助?哪些是违规求助? 3514055
关于积分的说明 11171564
捐赠科研通 3249344
什么是DOI,文献DOI怎么找? 1794799
邀请新用户注册赠送积分活动 875377
科研通“疑难数据库(出版商)”最低求助积分说明 804779